Table 3 |
||||||
|
Self-reported medication data from the patient questionnaire survey. |
||||||
| Drug category |
% of subjects taking drug by group |
Effect of intervention |
Effect of intervention adjusted for a difference between registers |
|||
|
|
||||||
| Control |
Intervention |
RR |
95% CI |
RR |
95% CI |
|
|
|
||||||
| Diabetes medication |
||||||
| Diet alone |
46.4 |
47.0 |
1.01 |
0.87, 1.18 |
1.02 |
0.89, 1.17 |
| Any oral hypoglycaemic (biguanide, sulphonylurea or thiazolidinediones) |
34.0 |
32.7 |
0.96 |
0.81, 1.14 |
0.96 |
0.81, 1.14 |
| Sulphonylurea |
19.7 |
18.6 |
0.94 |
0.75, 1.18 |
0.93 |
0.75, 1.16 |
| Metformin |
25.3 |
24.4 |
0.96 |
0.76, 1.22 |
0.97 |
0.77, 1.22 |
| Insulin |
24.4 |
26.8 |
1.10 |
0.84, 1.43 |
1.09 |
0.82, 1.37 |
| Cardiovascular disease and risk factor management |
||||||
| Any cardiovascular drug |
49.6 |
45.9 |
0.92 |
0.84, 1.01 |
0.93 |
0.85, 1.01 |
| Any anti-platelet drug |
25.4 |
22.9 |
0.90 |
0.74, 1.10 |
0.90 |
0.75, 1.10 |
| Aspirin |
31.6 |
28.5 |
0.90 |
0.75, 1.08 |
0.90 |
0.75, 1.08 |
| ACE inhibitor |
25.0 |
22.1 |
0.89 |
0.75, 1.05 |
0.89 |
0.76, 1.05 |
| Drugs primarily used asa antihypertensives (including ACE/A-G inhibitors) |
33.1 |
30.4 |
0.92 |
0.82, 1.03 |
0.92 |
0.83, 1.03 |
| Any lipid-lowering |
27.4 |
25.9 |
0.94 |
0.78, 1.14 |
0.95 |
0.78, 1.15 |
| Statins |
27.0 |
25.0 |
0.92 |
0.76, 1.12 |
0.93 |
0.77, 1.12 |
| Fibrates |
1.0 |
1.6 |
1.61 |
0.61, 4.27 |
1.59 |
0.60, 4.18 |
|
|
||||||
|
a. Categories of cardiovascular drugs can be prescribed for more than one purpose (e.g., beta-blockers may be used to treat hypertension but also treat angina), whereas individual drugs within categories (e.g., atenolol) may be better known to be used for a specific purpose. The drugs in this category were known to be used primarily as antihypertensives. |
||||||
|
Eccles et al. Implementation Science 2007 2:6 doi:10.1186/1748-5908-2-6 |
||||||
